Stock Pick – Page 48 – Curated Stock Market News

California officials reject subsidies for Musk’s SpaceX over Tesla spat

The snub comes as Musk has sparred with officials in Alameda County over his plans to resume production at the Tesla plant there, which was stopped because of the coronavirus. Five members of California’s Employment Training Panel voted to reject the proposal and two voted for it, with one member absent, after discussing Musk’s tweets on Tesla’s reopening and media reports of layoffs at SpaceX’s Hawthorne, California headquarters in recent years.

from Yahoo Finance https://ift.tt/2yPWF29

15 May 2020

Fed Warns of ‘Significant’ Hit to Asset Prices If Pandemic Grows

from Yahoo Finance https://ift.tt/3bD4OUR

15 May 2020

Gilead to end coronavirus drug trials, adding to access worry -researchers

from Yahoo Finance https://ift.tt/2yPOR0l

15 May 2020

California officials reject subsidies for Musk’s SpaceX over Tesla spat

Fed Warns of ‘Significant’ Hit to Asset Prices If Pandemic Grows

Gilead to end coronavirus drug trials, adding to access worry -researchers

South32 shares fall 10% from all-time high: Is the rally over?

Why Macquarie’s $321 million Shield problem is back in court

ASX shares investors are still buying despite volatility: survey

Buy, hold, sell: Aurizon, Car Group, Guzman y Gomez shares

Could this evolving development smash ASX lithium shares like Liontown, Mineral Resources and PLS?

Buy, hold, sell: Temple & Webster, Kelsian, Boss Energy shares

China Says Worst of Flooding Still to Come as Situation ‘Severe’

Moderna Receives Additional $472 Million from BARDA for COVID-19 Vaccine; Target Price $90

‘McRefugees’ lose restaurant shelter as Hong Kong battles third wave of Covid-19 cases

AstraZeneca bets up to $6 billion on new Daiichi cancer drug

The Latest

China Says Worst of Flooding Still to Come as Situation ‘Severe’

Moderna Receives Additional $472 Million from BARDA for COVID-19 Vaccine; Target Price $90

‘McRefugees’ lose restaurant shelter as Hong Kong battles third wave of Covid-19 cases

AstraZeneca bets up to $6 billion on new Daiichi cancer drug